Upadacitinib

  • Part D specialty tier in 80% of formularies (2026Q3)
  • Rinvoq

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Upadacitinib: storage and handling

Freezing
Not addressed
Room temperature
No allowance stated
Back into the refrigerator
Not addressed
Light
Not addressed
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

The label does not state a room-temperature allowance for this product.

Entered: 1 day at up to 77°F (25°C).

Contact the manufacturer at 1-800-274-6867 (the number printed on the label) about this product.

Where the label prints this number
Call your healthcare provider or 1-800-2-RINVOQ or 1-800-274-6867 if you need help or have any questions about how to give RINVOQ LQ the right way.
All storage statements on the label (8)
  • Store in the original bottle in order to protect from moisture.
  • RINVOQ LQ oral solution Store between 2°C to 30°C (36°F to 86°F).
  • Discard remaining oral solution 60 days after opening the bottle.
  • Close and store the bottle. a.
  • Store the bottle upright in the carton between uses. c.
  • Store the bottle in the carton between 36°F to 86°F (2°C to 30°C) in a cool, dark place. d.
  • Rinse and store the syringe. a.
  • Store the syringe in a clean, dry place.

FDA label version 101, effective June 30, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

98%of plans list it
98%of those: prior authorization
0%step therapy
98%quantity limit
97%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.